<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02607878</url>
  </required_header>
  <id_info>
    <org_study_id>432/14</org_study_id>
    <nct_id>NCT02607878</nct_id>
  </id_info>
  <brief_title>Automated Pupillometry for Coma Prognostication After Cardiac Arrest</brief_title>
  <official_title>Automated Pupillometry for Coma Prognostication After Cardiac Arrest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Vaudois</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Erasme University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera San Gerardo di Monza</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lund University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Catholic University of the Sacred Heart</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cochin Hospital, India</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier du Luxembourg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire Vaudois</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Sedation and therapeutic hypothermia (TH) delay neurological responses and might
      reduce the accuracy of clinical examination to predict outcome after cardiac arrest (CA).
      Electroencephalography (EEG) and somato-sensory evoked potentials (SSEP) might significantly
      improve prognostication of post-CA coma, however, EEG and SSEP are not always available and
      require specific expertise for their interpretation. Automated video pupillometry is a novel
      electronic device that contains an infrared light camera which enables to measure
      quantitatively the percentage of pupillary reaction to a calibrated light stimulation. In a
      recent study of a cohort of comatose CA survivors (n=50 patients) it was found that
      quantitative PLR was more accurate than standard PLR (manual pen light) in predicting 3-month
      outcome, irrespective of temperature and sedation, and had comparable prognostic accuracy
      than electrophysiological exams, including electroencephalography (EEG) and somato-sensory
      evoked potentials (SSEP).

      Aim of the study: In light of these promising results, the investigators would like to
      confirm the prognostic value of quantitative PLR in a large multicenter cohort of comatose
      post-CA patients.

      Design of the study: Prospective, multicenter, observational outcome trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study: Prospective, multicenter study. The study will be double-blinded, i.e. the
      clinician/nurse performing the tests will not be involved in patient care and clinicians in
      charge of patients will not be aware of automated pupillometry data. Patient care will not be
      influenced by pupillometry.

      Patient population:

      The investigators plan to include 500 comatose post-CA patients. The centers have been
      selected based on their expertise and publication track record on the topic, and because they
      are actively involved in the Neurointensive Care section (NIC) of the European Society of
      Intensive Care Medicine (ESICM). The study will take place at the Department of Intensive
      Care of the participating centers.

      Patients will be managed according to standards of post-resuscitation care and based on local
      algorithms for the treatment of post-CA coma.

      Quantitative pupillary light reactivity (PLR, using the NeurOptics NPi-200 pupillometer) will
      be performed on ICU admission and then every 12 hours up to 72 hours after CA. At each time
      point, one measurement will be assessed on both eyes.

      The primary variables for analysis will be the neurological pupil index (NPi) and the pupil
      size for both eyes. Standard PLR using a manual pen light will be performed simultaneously at
      each time point, as part of standard care.

      EEG, SSEP and sampling for serum neuron specific enolase (NSE) will be performed at 24h and
      at 48-72h, according to local practices and as part of standard care.

      The predictive value of NPi will be analyzed using the area under the receiving operator
      characteristics (ROC) curve, and compared to that of standard PLR, EEG, SSEP and NSE:
      sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV),
      unweighted accuracy, with 95% binomial confidence intervals, will be calculated. Associations
      with outcome will adjusted for main baseline demographics (age, initial CA arrest rhythm,
      time from CA to tROSC), dose of sedation-analgesia and vaso-active agents, and the SOFA
      score, using a logistic regression model.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Neurological outcome</measure>
    <time_frame>3-6 months</time_frame>
    <description>Neurological outcome is assessed by a semi-structured telephone interview with the patient or the patient's relatives using the Glasgow-Pittsburgh Cerebral Performance Categories (CPC). The CPC result is then categorized as favorable outcome (CPC 1-2, including good recovery and moderate disability), vs. unfavorable outcome (CPC 3-5, including severe disability, vegetative state and death).</description>
  </primary_outcome>
  <enrollment type="Actual">470</enrollment>
  <condition>Cardiac Arrest</condition>
  <condition>Comatose</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with coma after cardiac arrest (CA)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients with coma after cardiac arrest (CA)

          -  Glasgow Coma Scale (at inclusion): ≤ 6

          -  Patients with CA due to ventricular fibrillation (VF) and non-VF (including asystole
             and pulseless electrical activity) rhythms

          -  Cardiac and non-cardiac causes of CA will be included

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Unable to obtain consent

          -  Follow-up unavailable
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mauro Oddo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHUV, Lausanne University Hospital, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Erasme University Hospital</name>
      <address>
        <city>Brussels</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital, Grenoble</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cochin Hospital</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charite University, Berlin, Germany</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera San Gerardo di Monza</name>
      <address>
        <city>Monza</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catholic University of the Sacred Heart</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier du Luxembourg</name>
      <address>
        <city>Luxembourg</city>
        <country>Luxembourg</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lund University Hospital</name>
      <address>
        <city>Lund</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHUV, Lausanne University Hospital</name>
      <address>
        <city>Lausanne</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Luxembourg</country>
    <country>Netherlands</country>
    <country>Sweden</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 2, 2015</study_first_submitted>
  <study_first_submitted_qc>November 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2015</study_first_posted>
  <last_update_submitted>March 30, 2018</last_update_submitted>
  <last_update_submitted_qc>March 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Vaudois</investigator_affiliation>
    <investigator_full_name>Mauro ODDO</investigator_full_name>
    <investigator_title>Médecin adjoint, PD-MER I</investigator_title>
  </responsible_party>
  <keyword>Cardiac arrest</keyword>
  <keyword>Coma</keyword>
  <keyword>Prognosis</keyword>
  <keyword>Automated pupillometry</keyword>
  <keyword>EEG</keyword>
  <keyword>Evoked potentials</keyword>
  <keyword>Targeted Temperature Management (TTM)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

